1Vertex Pharmaceuticals, Inc., Cambridge, MA, USA. Ene_Ette@vpharm.com
Population pharmacokinetic (PPK) modeling offers significant advantages for drug development and patient care. This approach quantifies variability in drug disposition within patient groups, aiding in optimized dosing strategies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: